Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2020

Open Access 01-12-2020 | Cystocele | Study protocol

Protocol for a randomized controlled trial to assess two procedures of vaginal native tissue repair for pelvic organ prolapse at the time of the questioning on vaginal prosthesis: the TAPP trial

Authors: A. Lacorre, F. Vidal, S. Campagne-Loiseau, B. Marin, Y. Aubard, F. Siegerth, C. Mesnard, E. Chantalat, C. Hocke, T. Gauthier

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Native tissue cystocele repair has been the cornerstone of prolapse surgery, especially since the learned societies warned clinicians and patients about serious mesh-related complications. Surgical techniques mainly consist in anterior colporraphy and vaginal patch plastron. However, success rates of native tissue cystocele repair are heterogeneous, depending on the design of studies and definition of outcomes. To date, high-quality data comparing vaginal native tissue procedures are still lacking.

Methods

Herein we aimed to describe the design of the first randomized controlled trial (TAPP) comparing anterior colporraphy (plication of the muscularis and adventitial layers of the vaginal wall) and vaginal patch plastron (bladder support anchored on the tendinous arch of the pelvic fascia by lateral sutures) techniques.
Our aim is to assess the effectiveness of vaginal native tissue repair at 1 year for cystocele with a combined definition of success—anatomic and functional. The primary endpoint will be the success rate 1 year after surgery with a composite of objective and subjective measures (Aa and Ba points < 0 from POP-Q (Pelvic Organ Prolapse Quantification System) and a negative answer to question 3 of Pelvic Floor Distress Inventory and no need for additional treatment).

Discussion

A prospective study has found a success rate at 35% for anterior colporraphy based on a combined definition, both anatomic and functional, as recently recommended. However, the definition of anatomic was strict (POP-Q< 2), while it seems that the best definition of anatomic success is “no prolapse among the hymen”, that is to say Aa and Ba points from the POP-Q classification < 0. We hypothesize that vaginal patch plastron will have a better anatomic and functional success comparatively to anterior colporraphy because native tissue is added, as it corrects both median and lateral cystoceles thanks to bilateral paravaginal suspension.

Trial registration

CHU LIMOGES is the sponsor of this research (n°87RI18_0013).
This research is supported by the French Department of Health (PHRC 2018-A03476-49) and will be conducted with the support of DGOS (PHRC interregional – GIRCI SOHO).
The study protocol was approved by the Human Subjects Protection Review Board (Comité de Protection des Personnes) on May 16, 2019.
The trial is registered in the ClinicalTrials.gov registry (NCT03875989).
Appendix
Available only for authorised users
Literature
1.
Le Normand L, Cosson M, Cour F, Deffieux X, Donon L, Ferry P, et al. Clinical practice guidelines: synthesis of the guidelines for the surgical treatment of primary pelvic organ prolapse in women by the AFU, CNGOF, SIFUD-PP, SNFCP, and SCGP. J Gynecol Obstet Hum Reprod. 2017;46(5):387–91.CrossRef
2.
HAS. Evaluation des implants de renfort pour le traitement de l’incontinence urinaire d’effort fémnine et du pralpasus des organes pelviens chez la femme. 2007.
3.
FDA. Urogynecologic mesh: update on the safety and effectiveness of the transvaginal placement for pelvic organ prolapse. 2011.
4.
CNGOF. Communiqué de Presse: Chirurgie des prolapsus génitaux et de l’incontinence urinaire. 2018.
5.
Savary D, Bruyere A, Campagne Loiseau S, Jacquetin B. Chirurgie de la cystocèle par voie vaginale: techniques sans prothèse. CNGOF. 2012.
6.
Altman D, Väyrynen T, Engh ME, Axelsen S, Falconer C, Nordic Transvaginal Mesh Group. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med. 2011;364(19):1826–36.CrossRef
7.
Lucot J-P, Fritel X, Debodinance P, Bader G, Cosson M, Giraudet G, et al. PROSPERE randomized controlled trial: laparoscopic sacropexy versus vaginal mesh for cystocele POP repair. J Gynecol Obstet Biol Reprod (Paris). 2013;42(4):334–41.CrossRef
8.
Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Marjoribanks J. Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse. Cochrane Database Syst Rev. 2016;2:CD012079.PubMed
9.
10.
Weber AM, Walters MD, Piedmonte MR, Ballard LA. Anterior colporrhaphy: a randomized trial of three surgical techniques. Am J Obstet Gynecol. 2001;185(6):1299–304. discussion 1304-1306.CrossRef
11.
Menefee SA, Dyer KY, Lukacz ES, Simsiman AJ, Luber KM, Nguyen JN. Colporrhaphy compared with mesh or graft-reinforced vaginal paravaginal repair for anterior vaginal wall prolapse: a randomized controlled trial. Obstet Gynecol. 2011;118(6):1337–44.CrossRef
12.
Iyer S, Seitz M, Tran A, Scalabrin Reis R, Botros C, Lozo S, et al. Anterior colporrhaphy with and without dermal allograft: a randomized control trial with long-term follow-up. Female Pelvic Med Reconstr Surg. 2019;25(3):206–12.CrossRef
13.
Nüssler E, Kesmodel US, Löfgren M, Nüssler EK. Operation for primary cystocele with anterior colporrhaphy or non-absorbable mesh: patient-reported outcomes. Int Urogynecology J. 2015;26(3):359–66.
14.
Querleu D., Crepin G., Blanc B. Prolapsus génitaux. EMC Gynécologie Techniques Chirurgicales 1991.
15.
Chen Z, Wong V, Wang A, Moore KH. Nine-year objective and subjective follow-up of the ultra-lateral anterior repair for cystocele. Int Urogynecology J. 2014;25(3):387–92.CrossRef
16.
Cosson M, Collinet P, Occelli B, Narducci F, Crépin G. The vaginal patch plastron for vaginal cure of cystocele. Preliminary results for 47 patients. Eur J Obstet Gynecol Reprod Biol. 2001;95(1):73–80.CrossRef
17.
Barber MD, Brubaker L, Nygaard I, Wheeler TL, Schaffer J, Chen Z, et al. Defining success after surgery for pelvic organ prolapse. Obstet Gynecol. 2009;114(3):600–9.CrossRef
18.
Srikrishna S, Robinson D, Cardozo L. Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse. Int Urogynecology J. 2010;21(5):523–8.CrossRef
19.
Fatton B, Letouzey V, Lagrange E, Mares P, Jacquetin B, de Tayrac R. Validation of a French version of the short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12). J Gynecol Obstet Biol Reprod (Paris). 2009;38(8):662–7.CrossRef
20.
Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.CrossRef
21.
de Tayrac R, Deval B, Fernandez H, Marès P, Mapi Research Institute. Development of a linguistically validated French version of two short-form, condition-specific quality of life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). J Gynecol Obstet Biol Reprod (Paris). 2007;36(8):738–48.CrossRef
22.
Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193(1):103–13.CrossRef
23.
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205–13.CrossRef
Metadata
Title
Protocol for a randomized controlled trial to assess two procedures of vaginal native tissue repair for pelvic organ prolapse at the time of the questioning on vaginal prosthesis: the TAPP trial
Authors
A. Lacorre
F. Vidal
S. Campagne-Loiseau
B. Marin
Y. Aubard
F. Siegerth
C. Mesnard
E. Chantalat
C. Hocke
T. Gauthier
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04512-x

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue

Study protocol

Effect of a probiotic on blood pressure in grade 1 hypertension (HYPRO): protocol of a randomized controlled study

Correction

Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study

Study protocol

Measurement of cerebrovascular reserve by multimodal imaging for cerebral arterial occlusion or stenosis patients: protocol of a prospective, randomized, controlled clinical study

Study protocol

A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: protocol and rationale of the Take a STAND for Health study

Study protocol

Sustainable, healthy cities: protocol of a mixed methods evaluation of a cluster randomized controlled trial for Aedes control in Brazil using a community mobilization approach

Letter

Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial